GTx Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
14,729.00
49,295.00
29,256.00
21,869.00
43,899.00
Other Current Assets
442.00
856.00
2,633.00
2,429.00
2,178.00
Total Current Assets
15,171.00
50,151.00
31,889.00
24,298.00
46,077.00
Net Property, Plant & Equipment
112.00
29.00
5.00
81.00
51.00
Intangible Assets
166.00
152.00
137.00
123.00
108.00
Other Assets
156.00
319.00
-
-
-
Total Assets
15,605.00
50,651.00
32,031.00
24,502.00
46,236.00
Accounts Payable
808.00
512.00
-
1,220.00
2,604.00
Income Tax Payable
156.00
319.00
-
-
-
Other Current Liabilities
3,603.00
31,961.00
30,172.00
3,391.00
5,371.00
Total Current Liabilities
4,567.00
32,792.00
30,172.00
4,611.00
7,975.00
Other Liabilities
354.00
30.00
-
-
-
Total Liabilities
4,921.00
32,822.00
30,172.00
4,611.00
7,975.00
Common Equity (Total)
10,684.00
17,829.00
1,859.00
19,891.00
38,261.00
Total Shareholders' Equity
10,684.00
17,829.00
1,859.00
19,891.00
38,261.00
Total Equity
10,684.00
17,829.00
1,859.00
19,891.00
38,261.00
Liabilities & Shareholders' Equity
15,605.00
50,651.00
32,031.00
24,502.00
46,236.00

About GTx

View Profile
Address
175 Toyota Plaza
Memphis Tennessee 38103
United States
Employees -
Website http://www.gtxinc.com
Updated 09/14/2018
GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development and commercialization of small molecules for the treatment of cancer, including treatments for breast and prostate cancer, and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN.